Do have antidepressants of the second generation anxiolytic properties?
D000328:Adult; D000873:Anthracenes / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D008376:Maprotiline / Q000627:therapeutic use*; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D009627:Nomifensine / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D014745:Viloxazine / Q000627:therapeutic use*
D000873:Anthracenes; D007546:Isoquinolines; D009025:Morpholines; D009627:Nomifensine; D008376:Maprotiline; D014745:Viloxazine